Drug intelligence / Profile preview

Peking Univ. GPX4 compound 8e

Development stage
Preclinical
Lead developer
Peking University
Modality
PROTACs (E3 ligase recruitment) → Targeted Protein Degraders (TPDs) → Small Molecules
01

Overview

Peking Univ. GPX4 compound 8e: sourced facts only. name: "Hence, 8e was discovered as a potent and highly efficacious GPX4 degrader based upon the inhibitor RSL3." [PMID:36603510]; target: "Hence, 8e was discovered as a potent and highly efficacious GPX4 degrader based upon the inhibitor RSL3." [PMID:36603510]; developer: "Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Peking University, Beijing, China. Electronic address: [email protected]." [PMID:36603510]; modality: "we designed and synthesized a series of GPX4 degraders using PROTAC technology in terms of its excellent characteristics such as high efficiency and selectivity and the capacity of overcoming resistance." [PMID:36603510]; stage: "Our data also suggested that 8e and RSL3 could potently induce ferroptosis of HT1080 cells via GPX4 inhibition and degradation." [PMID:36603510]

02

Targets

GPX4 (Glutathione peroxidase 4)

Beyond the preview

Go deeper on Peking Univ. GPX4 compound 8e.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peking Univ. GPX4 compound 8e.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call